Detecting and Characterizing AAV Capsid Proteins and Transgenes in Gene Therapy Applications
In this webinar our speakers will introduce NanoMosaic’s Tessie™, a fit-for-purpose platform for gene therapy applications that effectively combines protein and nucleic acid quantification in a single run. During the webinar, they will discuss how Tessie detects and characterizes AAV capsids as well as full, empty, partial, and internally deleted transgenes directly from crude extracts.
![](https://cdn.prod.website-files.com/65e210fe59520c7a193b8ce7/660ea652d39abded06ac48dd_2024-04-0415.06.26-ezgif.com-optimize.gif)